Condition: Idiopathic Gastroparesis · Sponsor: CinDome Pharma, Inc.
The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with idiopathic gastroparesis compared to a placebo * To evaluate the safety of CIN-102 when given to patients with idiopathic gastroparesis compared to a placebo Participants will go through the following schedule: * Pre-screening (1 visit) * Screening \& Lead-In (1-2 visits) * Will complete a Gastric Emptying Breath Test (GEBT) * Will complete daily diary and other Patient Reported Outcomes (PROs) as described in the protocol to assess eligibility for continued study participation. * Lead-In Period (1 visit) * 12-week treatment period (7 visits) * Study drug taken twice daily by mouth * Will complete daily diaries and other PROs as described in protocol * 1 week follow-up (1 visit) Researchers will compare the effects of the following treatments: * 15 mg CIN-102, taken orally BID for 12 weeks * 10 mg CIN-102, taken orally BID for 12 weeks * Placebo for CIN-102, taken orally BID for 12 weeks
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Gastro Health - Birmingham | Birmingham, Alabama, United States | — |
| G & L Research, LLC | Foley, Alabama, United States | — |
| The Center for Clinical Trials | Saraland, Alabama, United States | — |
| Del Sol Research Management, LLC | Tucson, Arizona, United States | — |
| Applied Research Center of Arkansas, Inc | Little Rock, Arkansas, United States | — |
| Preferred Research Partners, Inc. | Little Rock, Arkansas, United States | — |
| Hope Clinical Research LLC | Canoga Park, California, United States | — |
| Erick H. Alayo Medical Corporation | Chula Vista, California, United States | — |
| Flourish Research - Los Angeles (Covina) | Covina, California, United States | — |
| Gastro Care Institute | Lancaster, California, United States | — |
| Downtown L.A. Research Center, Inc. | Los Angeles, California, United States | — |
| Acclaim Clinical Research | San Diego, California, United States | — |
+ 73 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.